The majority of myeloproliferative neoplasms (MPN) cases are caused by somatic mutations in bone marrow stem cells. While MPN is not currently curable, there is strong potential for targeted treatment by understanding this disease at the single-cell level.
REQUEST A QUOTE
Advance your understanding of the genetic heterogeneity underpinning myeloproliferative neoplasms (MPN) by targeting 24 genes with 123 amplicons for single-cell sequencing. Covering a combination of oncogenes and tumor suppressor genes, this panel is designed to cover some of the most commonly mutated genes associated with MPN.
DOWNLOAD DATASHEET
Use Tapestri Designer to add or remove content from existing catalog panels and make this panel your own with content that is relevant to your research. Or start from scratch and upload your human (hg19) or mouse (mm10) targets using gene names, genomic coordinates, or SNV IDs. Target anywhere in the whole human or mouse genome and advance your research with targeted single-cell DNA sequencing.
DESIGN PANEL
